Back to BlackRock, Inc. BlackRock, Inc.

DRUGDRUG
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in BRIGHT MINDS BIOSCIENCES INC

BlackRock, Inc. holds 686,184 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), worth $48.2M as of 2026-Q2. The position was increased (+10.3% shares). DRUG represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$48.2M

Current Shares

686,184

Total Value Change

+$48.2M

Total Shares Change

+686,183

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
686,184
+10.3%
$48.2M0.0%$70.20
32
2026-Q1
Increased
621,933
+57.8%
$45.4M0.0%$80.00
42
2025-Q4
Increased
394,043
+68.3%
$30.8M0.0%$75.85
43
2025-Q3
Increased
234,118
+11.7%
$14.2M0.0%$57.45
31
2025-Q2
Increased
209,677
+308x
$5.5M0.0%$23.27
44
2025-Q1
Increased
678
+677x
$24,4550.0%$36.50
21
2024-Q4
New
1
-
$360.0%$36.86
17

Other major holders of DRUG: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used